Popular Today
Popular Today
Popular All Time
Charts and Videos
Charts and Videos
32 0 2
ACAD Start to the upside?

A possible corrective structure may be completed on NASDAQ:ACAD. This could have big upside potential. If we get a consolidation here I'd love to start trading it on the radar.

Dario1987 Dario1987 MYL, 1D, Long ,
13 0 1
MYL, 1D Long
MYL out of the bullish wedge new buy long

The price has closed above the downtrend line started this year with consistent volumes. I opened a buy as I am expecting increasing volume and strenght in the next sessions. Tps are already highlighted on the right.

ToddGreen ToddGreen TCON, 1W, Long ,
59 0 1
TCON, 1W Long
TCON Tracon Pharmaceuticals, INC. Massive Gains, High Risk!

keeping it simple! We have seemed to reach the bottom 2$ mark once again, and have indicators of a bounce to the top of the wedge, and possible breakout! I see the moku cloud turning bullish slightly, and buy signals in this area firing. We had a weekly sqeeze fire short, which seems to be slowing down right about now, with noticable increased volume over the ...

23 0 2
CKPT, 1D Long

CKPT is breaking out on heavy volume. Primary Wave 1 Extension Daily: Levels: Target:

11 0 2
Bespoke - Billionaire pumped CBD stock watch

Bespoke is a CBD Oil from HEMP stock with all the dressings to grow, but was bubble busted over the past few weeks. Watching to buy only when 1) MACD crosses 0 and 2) CCI going into upward buy point (see earlier circled period ), or see area's for shorting. This stock simply was overvalued, oversold, and over-pumped by billionaire hoping to get rich pumping ...

intelitrades intelitrades MNKD, 60, Long ,
93 0 1
MNKD, 60 Long
MNKD - Next Resistance Level 1.5, or Reversal of DownTrend

Looking for a resistance level that causes a reversal of trend. You can see the 2.01 resistance level was hit on 9/6, and 9/7 the price fell through to 1.78. If the downward trend continues, the next resistance level to be hit would be 1.5. Substantial sell volume on 9/5, 9/6 and 9/7 could be indicative of a higher likelihood for a trend reversal early next ...

40 1 2
BHC close to buy zone

As showed in the chart $BHC comes from a long bullish flag. Price is reaching the buy zone where the major bullish trendline goes through. It's not yet a buy but we are approching such zone. Strategy: watch and wait.

JosePips JosePips PGNX, 240, Long ,
85 3 1
PGNX, 240 Long

PGNX POTENTIAL LONG I had made a post on August 28th for a potential long opportunity on this pair. After letting the market play out for a few days it has given me a better structural trade and better looking potential long opportunity for what I like to trade. This pair had made a strong push from the $7.30 price area to the $9.30 price area back in late ...

shaungomez8 shaungomez8 NEPT, 30, Long ,
46 0 2
NEPT, 30 Long

I read an article today that they are to provide the oils for CGC

JosePips JosePips PGNX, 1D, Long ,
45 2 2
PGNX, 1D Long

PGNX POTENTIAL LONG 1W Chart: * on the weekly chart if you look at recent data it is displaying the fact that the recent buyers are a lot stronger than the sellers *one candle up from the buyer took out 6 candles down from the sellers 1D Chart: *on this chart it is displaying the fact that the recent buyer had pushed price up above 4H structure and seems to ...

Thisguy22 Thisguy22 OVID, 1D, Long ,
19 0 3
OVID, 1D Long
OVID time to get high.....on gains

Pharmaceutical company these are starting to become my new drug. Propah gains to be made! This thing moves fast af! bullish all the way.

38 0 2
$BHC almost a buy: under the radar

I am waiting for an entry long in $BHC but positive signs are already there especially RSI is giving an insight, MA 200 is almost close and it might be probable a new test. Monthly RSI is down and on a weekly basis price is approcing the pullback of the third bullish wave. For the time being, given the positive earnings release a bullish trend continuation is ...

13 0 2
BLRX, 1D Long
BLRX - BioLine RX - Promising Biotech with Big upside - Long

BLRX BL-8040 Overview BL-8040 is a novel, short peptide that functions as a high-affinity antagonist for CXCR4, which BioLineRx is developing for the treatment of solid tumors, acute myeloid leukemia, or AML, and stem-cell mobilization for bone-marrow transplantation. Solid Tumors: In January 2016, BioLineRx entered into a collaboration with MSD, known as Merck ...

37 0 1
ENDP, 1M Long

ENDP Endo International plc is a highly focused generics and specialty branded pharmaceutical company delivering quality medicines through excellence in development, manufacturing and commercialization. Through our operating companies – Endo Pharmaceuticals, Par Pharmaceutical and Paladin Labs – Endo is dedicated to serving patients in need. Endo commenced ...

Dario1987 Dario1987 MYL, 1D, Long ,
28 0 2
MYL, 1D Long
MYL: wedge about to be completed

$MYL: Bullish wedge is about to be completed as yesterday we have seen rising bullish pressure, actually price wasn't able to break out the upper edge and we have seen a sharp intraday pullback (about 3%). Today buyers are coming in, thus price is heading upper edge. Volumes are rising, MACD on a weekly basis turn positive. Test of mid and long term support as ...

22 0 2
Novartis almost a buy

Pharmaceutical stocks represents a defensive asset when a positive market cycle is about to finish or when it is foreseen a cycle less positive than the previous one. In such context pharma stocks should have an advantage because of inelastic demand for such goods. Novartis ($NVS,$NOVN) is one of the candidate to break up as the price is moving in a triangle ...

21 0 2
($VRTX) Vertex: a buy only after a break out

Vertex has consolidating the price in a bullish wedge. A key resistence zone is at 178.57, a break out of such edge is interesting because it might pull up the price toward new high records. Stock is under the radar

Dario1987 Dario1987 CELG, 1D, Long ,
113 0 3
CELG, 1D Long
($celg) Celgene: not so fast

Celgene helped by the company's buyback has turned positive after a complicated year. Despite this in terms of foundamentals two drugs are on the way to be developped but such developments will be revealed in the next year so patient is a must for those who wants to invest of something concreate. On a technical point of view yesterday price faild to cross MA 200. ...

Show More Ideas 123456
EN English
EN English (UK)
EN English (IN)
DE Deutsch
FR Français
ES Español
IT Italiano
PL Polski
SV Svenska
TR Türkçe
RU Русский
PT Português
ID Bahasa Indonesia
MS Bahasa Melayu
TH ภาษาไทย
VI Tiếng Việt
JA 日本語
KO 한국어
ZH 简体中文
ZH 繁體中文
AR العربية
HE עברית
Home Stock Screener Forex Screener Crypto Screener Economic Calendar How It Works Chart Features House Rules Moderators Website & Broker Solutions Widgets Stock Charting Library Feature Request Blog & News FAQ Help & Wiki Twitter
Profile Profile Settings Account and Billing My Support Tickets Contact Support Ideas Published Followers Following Private Messages Chat Sign Out